journal article·2019-10-14Open access

High-Throughput Cell Motility Studies on Surface-Bound Protein Nanoparticles with Diverse Structural and Compositional Characteristics

Witold I. Tatkiewicz, Joaquin Seras-Franzoso, Elena García-Fruitós, Esther Vazquez, Adriana R. Kyvik, Nora Ventosa, Judith Guasch, Antonio Villaverde, Jaume Veciana, Imma Ratera

Abstract

Eighty areas with different structural and compositional characteristics made of bacterial inclusion bodies formed by the fibroblast growth factor (FGF-IBs) were simultaneously patterned on a glass surface with an evaporation-assisted method that relies on the coffee-drop effect. The resulting surface patterned with these protein nanoparticles enabled to perform a high-throughput study of the motility of NIH-3T3 fibroblasts under different conditions including the gradient steepness, particle concentrations, and area widths of patterned FGF-IBs, using for the data analysis a methodology that includes "heat maps". From this analysis, we observed that gradients of concentrations of surface-bound FGF-IBs stimulate the total cell movement but do not affect the total net distances traveled by cells. Moreover, cells tend to move toward an optimal intermediate FGF-IB concentration (i.e., cells seeded on areas with high IB concentrations moved toward areas with lower concentrations and vice versa, reaching the optimal concentration). Additionally, a higher motility was obtained when cells were deposited on narrow and highly concentrated areas with IBs. FGF-IBs can be therefore used to enhance and guide cell migration, confirming that the decoration of surfaces with such IB-like protein nanoparticles is a promising platform for regenerative medicine and tissue engineering.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Spaceflight effects on biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Molecular Nanoscience and Organic Materials, Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Bellaterra, Spain

CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08193 Bellaterra, Spain

Dynamic Biomimetics for Cancer Immunotherapy, Max Planck Partner Group, ICMAB-CSIC, Campus UAB, 08193 Bellaterra, Spain

Funding

Ministerio de Econom??a y Competitividad · European Commission · Centro de Investigaci??n Biom??dica en Red en Bioingenier??a, Biomateriales y Nanomedicina · Fundaci??n Cient??fica Asociaci??n Espa??ola Contra el C??ncer · Instituto Nacional de Investigaci??n y Tecnolog??a Agraria y Alimentaria · European Cooperation in Science and Technology · Max-Planck-Gesellschaft · Generalitat de Catalunya · Instituci?? Catalana de Recerca i Estudis Avan??ats · Ag??ncia per a la Competitivitat de l'Empresa

References (54)

Show source-provided references
1. 10.1126/science.110658710.1126/science.1106587 ↗
2. 10.1146/annurev-cellbio-092910-15404310.1146/annurev-cellbio-092910-154043 ↗
3. 10.1242/dev.10145110.1242/dev.101451 ↗
4. Concha M. L. · Development · 1998 · 125 · 98310.1242/dev.125.6.983 ↗
5. 10.1007/s00281-014-0418-810.1007/s00281-014-0418-8 ↗
6. 10.1038/nature0688710.1038/nature06887 ↗
7. Carlier M.-F. · 201010.1007/978-90-481-9301-1 ↗
8. 10.1083/jcb.20090900310.1083/jcb.200909003 ↗
9. 10.1038/nrm272910.1038/nrm2729 ↗
10. 10.1371/journal.pone.007637310.1371/journal.pone.0076373 ↗
11. 10.1021/la203725a10.1021/la203725a ↗
12. 10.1124/jpet.109.16039010.1124/jpet.109.160390 ↗
13. 10.1021/acsomega.8b0052110.1021/acsomega.8b00521 ↗
14. 10.1021/acs.chemmater.5b0491010.1021/acs.chemmater.5b04910 ↗
15. 10.1002/adma.20150090010.1002/adma.201500900 ↗
16. 10.1002/chem.20130147810.1002/chem.201301478 ↗
17. 10.1016/j.bpj.2014.08.00110.1016/j.bpj.2014.08.001 ↗
18. 10.1073/pnas.131438511010.1073/pnas.1314385110 ↗
19. Maheshwari G. · J. Cell Sci. · 2000 · 113 · 167710.1242/jcs.113.10.1677 ↗
20. 10.1093/emboj/18.14.390910.1093/emboj/18.14.3909 ↗
21. 10.1021/acs.jpcb.8b0165210.1021/acs.jpcb.8b01652 ↗
22. 10.1021/acs.nanolett.7b0263610.1021/acs.nanolett.7b02636 ↗
23. 10.1126/science.111699510.1126/science.1116995 ↗
24. 10.1038/nrm185810.1038/nrm1858 ↗
25. 10.1016/j.ceb.2014.05.01010.1016/j.ceb.2014.05.010 ↗
26. 10.3791/27110.3791/271 ↗
27. 10.1039/c0ib00055h10.1039/c0ib00055h ↗
28. 10.1146/annurev.bioeng.7.060804.10034010.1146/annurev.bioeng.7.060804.100340 ↗
29. 10.1039/C3LC50959A10.1039/C3LC50959A ↗
30. 10.1021/la102640w10.1021/la102640w ↗
31. 10.1126/science.122845610.1126/science.1228456 ↗
32. 10.1146/annurev.immunol.23.021704.11562810.1146/annurev.immunol.23.021704.115628 ↗
33. 10.1002/btpr.186110.1002/btpr.1861 ↗
34. 10.1016/j.nano.2011.08.00110.1016/j.nano.2011.08.001 ↗
35. 10.1021/la302563810.1021/la3025638 ↗
36. 10.1016/j.ceb.2011.12.00210.1016/j.ceb.2011.12.002 ↗
37. 10.1002/aic.69039121010.1002/aic.690391210 ↗
38. 10.1002/aic.1416410.1002/aic.14164 ↗
39. 10.1088/1367-2630/16/7/07501210.1088/1367-2630/16/7/075012 ↗
40. 10.3303/CET143808710.3303/CET1438087 ↗
41. 10.1126/science.106921010.1126/science.1069210 ↗
42. 10.1016/j.actbio.2013.12.02110.1016/j.actbio.2013.12.021 ↗
43. 10.1021/nn400907f10.1021/nn400907f ↗
44. 10.2217/nnm.12.18810.2217/nnm.12.188 ↗
45. 10.1016/j.tibs.2017.01.00510.1016/j.tibs.2017.01.005 ↗
46. 10.1016/j.jconrel.2018.04.00410.1016/j.jconrel.2018.04.004 ↗
47. 10.1038/srep3576510.1038/srep35765 ↗
48. 10.1002/adhm.20150040210.1002/adhm.201500402 ↗
49. 10.1186/s12934-018-0904-010.1186/s12934-018-0904-0 ↗
50. 10.1021/acsami.8b0682110.1021/acsami.8b06821 ↗
51. 10.1038/nrd336810.1038/nrd3368 ↗
52. 10.1038/s41598-018-22598-x10.1038/s41598-018-22598-x ↗
53. 10.2147/IJN.S8300710.2147/IJN.S83007 ↗
54. 10.3390/ijms1709143910.3390/ijms17091439 ↗